STOCK TITAN

[Form 4] Sera Prognostics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Sera Prognostics insider sale reported. Paul Kearney, Chief Data Officer, filed a Form 4 disclosing a sale of 10,542 shares of Class A common stock on 08/29/2025 at a reported price of $3.49 per share. After the transaction Mr. Kearney beneficially owned 178,398 shares, held directly. The filing states the trade was executed under a Rule 10b5-1 trading plan adopted May 21, 2025, indicating the sale was preplanned rather than a discretionary transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/02/2025.

Segnalata vendita da insider di Sera Prognostics. Paul Kearney, Chief Data Officer, ha presentato un Modulo 4 che rende noto la vendita di 10.542 azioni di azioni ordinarie Classe A il 29/08/2025 al prezzo riportato di $3,49 per azione. Dopo l'operazione, il sig. Kearney deteneva direttamente 178.398 azioni. Il modulo indica che la vendita è stata eseguita nell'ambito di un piano di trading conforme alla Rule 10b5-1 adottato il 21 maggio 2025, segnalando che si trattava di un'operazione programmata e non discrezionale. Il Modulo 4 è stato firmato da un procuratore il 02/09/2025.

Reportada venta de insider de Sera Prognostics. Paul Kearney, Chief Data Officer, presentó un Formulario 4 divulgando la venta de 10.542 acciones de acciones ordinarias Clase A el 29/08/2025 a un precio reportado de $3.49 por acción. Tras la transacción, el Sr. Kearney poseía directamente 178.398 acciones. La presentación indica que la operación se realizó bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 21 de mayo de 2025, lo que indica que la venta fue preplanificada y no discrecional. El Formulario 4 fue firmado por un apoderado en nombre de la persona informante el 02/09/2025.

Sera Prognostics 내부자 매도 신고. 최고데이터책임자(Chief Data Officer) Paul Kearney는 2025-08-29에 클래스 A 보통주 10,542주를 주당 $3.49에 매도했음을 기재한 Form 4를 제출했습니다. 거래 후 Kearney 씨는 직접 보유한 178,398주를 보유하고 있었습니다. 제출서류에는 해당 매도가 2025년 5월 21일 채택된 Rule 10b5-1 거래계획에 따라 실행되었으며, 이는 해당 매도가 사전 계획된 것이지 임의적 거래가 아님을 나타냅니다. Form 4는 2025-09-02에 보고자를 대신한 위임자가 서명했습니다.

Vente d'initié de Sera Prognostics signalée. Paul Kearney, Chief Data Officer, a déposé un formulaire 4 divulguant la vente de 10 542 actions ordinaires de classe A le 29/08/2025 au prix déclaré de 3,49 $ par action. Après la transaction, M. Kearney détenait directement 178 398 actions. Le dépôt indique que la transaction a été exécutée dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 21 mai 2025, ce qui montre que la vente était préalablement planifiée et non discrétionnaire. Le formulaire 4 a été signé le 02/09/2025 par un mandataire au nom de la personne déclarante.

Insider-Verkauf von Sera Prognostics gemeldet. Paul Kearney, Chief Data Officer, reichte ein Formular 4 ein, das den Verkauf von 10.542 Aktien der Stammaktien Klasse A am 29.08.2025 zu einem gemeldeten Preis von $3,49 je Aktie offenlegt. Nach der Transaktion besaß Herr Kearney direkt 178.398 Aktien. In der Meldung heißt es, der Handel sei im Rahmen eines nach der Rule 10b5-1 am 21. Mai 2025 angenommenen Handelsplans ausgeführt worden, was darauf hindeutet, dass der Verkauf vorgeplant und nicht diskretionär war. Das Formular 4 wurde am 02.09.2025 von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

Positive
  • Transaction executed under a Rule 10b5-1 trading plan, indicating pre-authorized sale and compliance with insider-trading safeguards
  • Form 4 clearly discloses the reporting person\'s role as Chief Data Officer and provides post-transaction beneficial ownership
Negative
  • Insider disposed of 10,542 shares, reducing direct holdings to 178,398 shares
  • Sale occurred at $3.49 per share, which may be perceived negatively by some investors despite being under a preplanned program

Insights

TL;DR: Insider sold 10,542 shares under a 10b5-1 plan; transaction appears procedural, not an unscheduled divestiture.

The sale of 10,542 shares at $3.49 reduces the reporting person\'s direct holding to 178,398 shares. The explicit use of a Rule 10b5-1 plan adopted May 21, 2025, supports that the trade was pre-authorized and likely not based on nonpublic information. For investors, the quantitative impact is modest relative to typical outstanding share counts for public issuers; the filing does not disclose any derivative transactions or other changes in ownership form. No additional financial metrics or rationale for the plan are provided.

TL;DR: Governance processes followed: officer disclosed sale and 10b5-1 plan, consistent with compliance best practices.

The Form 4 clearly identifies the reporting person\'s role as Chief Data Officer and shows compliance with Section 16 reporting via a timely filing executed by an attorney-in-fact. Adoption of a 10b5-1 trading plan is a recognized mechanism to mitigate insider trading risk. The filing provides no indication of undisclosed related-party transactions, amendments, or coordination with other insiders. Material governance implications appear limited based solely on this disclosure.

Segnalata vendita da insider di Sera Prognostics. Paul Kearney, Chief Data Officer, ha presentato un Modulo 4 che rende noto la vendita di 10.542 azioni di azioni ordinarie Classe A il 29/08/2025 al prezzo riportato di $3,49 per azione. Dopo l'operazione, il sig. Kearney deteneva direttamente 178.398 azioni. Il modulo indica che la vendita è stata eseguita nell'ambito di un piano di trading conforme alla Rule 10b5-1 adottato il 21 maggio 2025, segnalando che si trattava di un'operazione programmata e non discrezionale. Il Modulo 4 è stato firmato da un procuratore il 02/09/2025.

Reportada venta de insider de Sera Prognostics. Paul Kearney, Chief Data Officer, presentó un Formulario 4 divulgando la venta de 10.542 acciones de acciones ordinarias Clase A el 29/08/2025 a un precio reportado de $3.49 por acción. Tras la transacción, el Sr. Kearney poseía directamente 178.398 acciones. La presentación indica que la operación se realizó bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 21 de mayo de 2025, lo que indica que la venta fue preplanificada y no discrecional. El Formulario 4 fue firmado por un apoderado en nombre de la persona informante el 02/09/2025.

Sera Prognostics 내부자 매도 신고. 최고데이터책임자(Chief Data Officer) Paul Kearney는 2025-08-29에 클래스 A 보통주 10,542주를 주당 $3.49에 매도했음을 기재한 Form 4를 제출했습니다. 거래 후 Kearney 씨는 직접 보유한 178,398주를 보유하고 있었습니다. 제출서류에는 해당 매도가 2025년 5월 21일 채택된 Rule 10b5-1 거래계획에 따라 실행되었으며, 이는 해당 매도가 사전 계획된 것이지 임의적 거래가 아님을 나타냅니다. Form 4는 2025-09-02에 보고자를 대신한 위임자가 서명했습니다.

Vente d'initié de Sera Prognostics signalée. Paul Kearney, Chief Data Officer, a déposé un formulaire 4 divulguant la vente de 10 542 actions ordinaires de classe A le 29/08/2025 au prix déclaré de 3,49 $ par action. Après la transaction, M. Kearney détenait directement 178 398 actions. Le dépôt indique que la transaction a été exécutée dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 21 mai 2025, ce qui montre que la vente était préalablement planifiée et non discrétionnaire. Le formulaire 4 a été signé le 02/09/2025 par un mandataire au nom de la personne déclarante.

Insider-Verkauf von Sera Prognostics gemeldet. Paul Kearney, Chief Data Officer, reichte ein Formular 4 ein, das den Verkauf von 10.542 Aktien der Stammaktien Klasse A am 29.08.2025 zu einem gemeldeten Preis von $3,49 je Aktie offenlegt. Nach der Transaktion besaß Herr Kearney direkt 178.398 Aktien. In der Meldung heißt es, der Handel sei im Rahmen eines nach der Rule 10b5-1 am 21. Mai 2025 angenommenen Handelsplans ausgeführt worden, was darauf hindeutet, dass der Verkauf vorgeplant und nicht diskretionär war. Das Formular 4 wurde am 02.09.2025 von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kearney Paul

(Last) (First) (Middle)
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200

(Street)
SALT LAKE CITY UT 84109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SERA PROGNOSTICS, INC. [ SERA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Data Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/29/2025 S(1) 10,542 D $3.49 178,398 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025.
/s/ Benjamin G. Jackson, Attorney-in-fact 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SERA insider Paul Kearney report on Form 4?

Mr. Kearney reported a sale of 10,542 Class A shares on 08/29/2025 at $3.49 per share and beneficial ownership of 178,398 shares after the sale.

Was the sale by the SERA insider part of a 10b5-1 plan?

Yes. The Form 4 states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted May 21, 2025.

What is Paul Kearney\\'s position at SERA?

He is listed as Chief Data Officer on the Form 4.

When was the Form 4 signed and filed?

The Form 4 was signed by an attorney-in-fact on 09/02/2025 and the reported transaction date was 08/29/2025.

Did the Form 4 report any derivative transactions?

No. Table II for derivative securities contains no reported transactions.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

122.94M
32.84M
10.87%
64.98%
3.27%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY